Related Experiment Videos
Evidence in a lethal infantile mitochondrial disease for a nuclear mutation affecting respiratory complexes I and IV
X Zheng1, J M Shoffner, M T Lott
1Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322.
Insights
A lethal infantile mitochondrial disease caused a child's death, linked to combined complex I and IV deficiency. The findings suggest a nuclear DNA mutation affecting specific genes in oxidative phosphorylation.
Area of Science:
- Biochemistry
- Genetics
- Pathology
Background:
- Mitochondrial diseases can cause severe infantile conditions, including cardiomyopathy.
- Understanding the genetic basis of these disorders is crucial for diagnosis and treatment.
Observation:
- A 4-month-old child with lethal infantile mitochondrial disease and cardiomyopathy exhibited abnormalities in muscle, heart, and liver, but not the central nervous system.
- Biochemical analysis revealed combined complex I and IV deficiency in affected tissues, while mitochondrial DNA and translation products were normal.
- Parental studies showed no abnormalities, suggesting a de novo mutation.
Findings:
- The study identified a combined complex I and IV deficiency in skeletal muscle, heart, and liver.
- Absence of abnormalities in mitochondrial DNA and translation products points away from primary mitochondrial genome defects.
- The pattern of tissue-specific and developmental stage-specific defects suggests a nuclear DNA mutation.
Implications:
- This case supports the hypothesis of nuclear DNA mutations affecting oxidative phosphorylation genes.
- Such mutations can lead to tissue-specific and developmental stage-specific mitochondrial disorders.
- Further research into nuclear gene mutations is vital for understanding and managing infantile mitochondrial diseases.
Abstract:
A child died at 4 months of age of a lethal infantile mitochondrial disease associated with cardiomyopathy. Detailed pathologic evaluation of this patient revealed abnormalities in the striated muscle, smooth muscle, heart, and liver, but not the central nervous system. Biochemical analysis revealed a combined complex I and IV deficiency in skeletal muscle, heart, and liver, but not in kidney and brain. Analysis of mitochondrial translation products and mitochondrial DNA failed to detect any abnormality. Parallel studies on both parents were uniformly normal. These data support the hypothesis that this disease was the result of a nuclear DNA mutation in a developmental stage-specific and tissue-specific oxidative phosphorylation-gene.